Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) Short Interest Update

Share on StockTwits

Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) saw a significant decrease in short interest in December. As of December 13th, there was short interest totalling 6,120,000 shares, a decrease of 8.0% from the November 28th total of 6,650,000 shares. Based on an average trading volume of 1,850,000 shares, the short-interest ratio is presently 3.3 days. Approximately 4.4% of the company’s shares are short sold.

MTNB has been the subject of a number of recent analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Matinas BioPharma in a report on Friday, December 20th. Maxim Group reaffirmed a “buy” rating and set a $3.00 price target on shares of Matinas BioPharma in a report on Thursday, September 26th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Matinas BioPharma has an average rating of “Buy” and a consensus target price of $3.60.

MTNB opened at $1.98 on Monday. The company has a fifty day simple moving average of $0.68 and a 200 day simple moving average of $0.89. Matinas BioPharma has a twelve month low of $0.57 and a twelve month high of $2.18.

Matinas BioPharma (NYSEAMERICAN:MTNB) last posted its quarterly earnings data on Wednesday, November 13th. The company reported ($0.03) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.03).

In other news, Director Patrick G. Lepore purchased 100,000 shares of the stock in a transaction that occurred on Friday, November 15th. The stock was acquired at an average cost of $1.15 per share, with a total value of $115,000.00. Also, CFO Keith A. Kucinski purchased 94,500 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average cost of $1.19 per share, with a total value of $112,455.00.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in Matinas BioPharma by 39.7% during the 2nd quarter. Vanguard Group Inc. now owns 4,997,918 shares of the company’s stock valued at $4,282,000 after acquiring an additional 1,419,118 shares during the last quarter. Staley Capital Advisers Inc. bought a new position in Matinas BioPharma during the 2nd quarter valued at $171,000. BlackRock Inc. boosted its stake in Matinas BioPharma by 5.0% during the 2nd quarter. BlackRock Inc. now owns 633,985 shares of the company’s stock valued at $543,000 after acquiring an additional 30,402 shares during the last quarter. Wells Fargo & Company MN boosted its stake in Matinas BioPharma by 297.2% during the 2nd quarter. Wells Fargo & Company MN now owns 103,274 shares of the company’s stock valued at $88,000 after acquiring an additional 77,274 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in Matinas BioPharma by 30.1% during the 2nd quarter. Northern Trust Corp now owns 236,818 shares of the company’s stock valued at $203,000 after acquiring an additional 54,852 shares during the last quarter.

Matinas BioPharma Company Profile

Matinas BioPharma Holdings, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable.

See Also: Balance Sheet

Receive News & Ratings for Matinas BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Bridgewater Bancshares Inc  Short Interest Update
Bridgewater Bancshares Inc Short Interest Update
CalAmp Corp.  Short Interest Up 24.1% in December
CalAmp Corp. Short Interest Up 24.1% in December
Short Interest in Sierra Bancorp  Rises By 24.8%
Short Interest in Sierra Bancorp Rises By 24.8%
Berry Petroleum Company LLC  Short Interest Update
Berry Petroleum Company LLC Short Interest Update
Short Interest in Popular Inc  Drops By 14.4%
Short Interest in Popular Inc Drops By 14.4%
Bank of Commerce Holdings  Sees Large Decline in Short Interest
Bank of Commerce Holdings Sees Large Decline in Short Interest


© 2006-2020 Ticker Report